Pharmaceutical industry

JAMP Pharma Group to acquire 100,000 square feet of Pharmalab Inc. manufacturing space

Drugmakers set to raise U.S. prices on at least 500 drugs in January

Ten per cent of prescription drugs linked to support programs sponsored by pharmaceutical companies: study

Health Canada to review U.S. panel’s conclusion that common decongestant doesn’t work

Naloxone kits across Canada should have both nasal spray and injection options, panel says

10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

Cannabis company Atlantic Cultivation acquires insolvent Tantalus Labs brand

Government signs new deal on generic drug pricing with pharmaceutical industry

Aurora Cannabis slashes Q1 net loss as hunt for savings continues

Canopy Growth sees $42-million net loss in Q1 as cost reduction efforts continue

Cannabis company TerrAscend to list on TSX under TSND ticker in early July

B.C. launching website to book appointments with pharmacists to treat minor ailments

Canopy Growth reports $648-million net loss in fourth-quarter as it parts way with BioSteel staff

NDP attempts to prod Liberals into action on pharmacare by tabling its own bill

Cannabis price ‘race to the bottom’ hurts market’s future, OCS CEO says

Industry blindsided by Ottawa’s plan to track ill effects of natural health products

Federal agency struggled to get pharma companies to engage in drug-price reform, memo shows

Ottawa resumes long-running battle over prescription drug prices

Health minister denies interfering in arm’s-length drug-price agency before committee

Cannabis shop robberies spur push to end restrictions on window displays

Health minister says stiffer regulations could prevent Ozempic-type prescribing

Head of Canada’s drug price regulator resigns same week as colleague steps down

Board member of federal drug-pricing agency resigns over concerns about panel’s independence

Aurora Cannabis records $67.2-million net loss in second quarter

Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close

B.C. ‘fight continues’ during decriminalization amid safe supply calls, advocacy group members say

Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug

As B.C. is poised for drug decriminalization experiment, will it help stem deadly tide?

Drugmakers to raise prices on at least 350 drugs in U.S. in January

Government, pharmaceutical industry deadlocked in negotiations over generic drug prices

GSK, Pfizer, Sanofi escape U.S. federal litigation over Zantac

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug

Generic drugmakers Teva and Sandoz make major push to biosimilars